Ex vivo glucocorticoid receptor-mediated IL-10 response predicts the course of depression severity
Open accessThe DOI matches its Crossref record; 72 of the 72 references it cites were found in a registry or an index; none of the 67 sources its claims cite is checked for support yet.
Abstract
Directly measuring hypothalamic pituitary adrenal (HPA) axis function, an important player in affective disorders, is intensive and invasive. A crucial component of this system, the activity of the glucocorticoid receptor (GR), can be assessed ex vivo instead. Here, we investigated GR sensitivity in patients with major depressive disorder (MDD) to determine its predictive potential. Psychometric data and blood samples were collected from patients experiencing a major depressive episode (MDE, n = 87), healthy control subjects (n = 49), and patients with remitted MDD (n = 31) at baseline and (for patients) after median 20 days of follow-up after treatment as usual. Blood cells were stimulated ex vivo with lipopolysaccharide and the effect was suppressed by increasing dexamethasone (DEX) concentrations. The resultant cytokine secretion profile (for IL-6, IL-10, and TNF-α) was considered indicative of GR activity. Higher baseline scores of the Montgomery–Åsberg Depression Rating Scale (MADRS) were associated with a stronger decrease of logIC IL-6 (indicating an increase of GR sensitivity). Higher baseline logEC IL-10 (indicating a lower GR sensitivity) and a stronger reduction of logEC IL-10 (indicating a stronger increase in GR sensitivity) were associated with a stronger decrease in the MADRS score. Patients with remitted MDD showed higher logIC TNF-α values (indicating lower GR sensitivity) in comparison to patients with a current MDD at baseline and follow-up. Initially low GR sensitivity measured ex vivo in peripheral blood cells that increases over the course of treatment could serve as a predictive marker for stronger improvement in depression severity.
Overview
CoChat Summary
TL;DR
In this ex vivo study, lower baseline glucocorticoid receptor sensitivity measured by logEC IL-10 and its increase over treatment predicted greater improvement in MADRS depression severity, while higher baseline MADRS predicted a stronger increase in GR sensitivity measured by logIC IL-6. Remitted MDD patients showed lower GR sensitivity via logIC TNF-α than currently depressed patients, but no baseline differences were found between current MDE and healthy controls.
Key findings
- Among patients with current MDE, greater decrease in MADRS from baseline to follow-up correlated with higher baseline logEC IL-10 (ρ = −0.230, P = 0.036) and with a stronger reduction in logEC IL-10 over follow-up (ρ = 0.333, P = 0.003); higher baseline MADRS correlated with a stronger decrease in logIC IL-6 (ρ = −0.226, P = 0.046).
- Patients with remitted MDD had higher logIC TNF-α (indicating lower GR sensitivity) than patients with current MDE at baseline (median 1.47 vs 1.35, P = 0.041) and at follow-up (P = 0.042).
- Current MDE patients did not differ significantly from healthy controls in cytokine response, and logIC IL-6, logEC IL-10, and logIC TNF-α did not significantly change from baseline to follow-up in current MDE patients.
- No significant correlations were found between GR sensitivity measures and BDI-II or HAMD scores.
Methods
- CeraBiDe study; baseline sample included 87 patients with current MDE, 49 healthy controls, and 31 patients with remitted MDD; 84 of 87 current MDE patients were followed after median 20 days (IQR 15–27; range 14–43) on treatment as usual; complete logIC/EC values were available for 167 subjects at baseline and 79 at follow-up.
- Whole blood was stimulated ex vivo with LPS 250 ng/ml and increasing dexamethasone concentrations (0 nM–100 µM), incubated 5.0 h at 37°C; IL-6, IL-10, and TNF-α were measured by ELISA, and logIC50 IL-6, logEC50 IL-10, and logIC50 TNF-α were calculated.
- Non-parametric analyses were used because data were not normally distributed: Mann–Whitney U, Wilcoxon, Spearman correlations, and Chi-square tests; P < 0.05 was considered significant; depression severity was assessed with BDI-II, HAMD, MADRS, and SKID-I.
Limitations
- Stated: associational design precludes causal conclusions; small sample and many excluded due to data quality control; no differentiation by episode duration, prior episodes, MDD subtype (e.g., anxious depression), or singular/recurrent episode; suicidal patients excluded; possible confounders (e.g., chronic fatigue syndrome, childhood trauma); many statistical tests raise false-positive risk; limited sample prevented sex-separate analyses; remitted MDD lacked follow-up, prior episode, and acute-episode HPA data.
- Stated: lack of significant BDI-II/HAMD findings could be due to small sample size or scale sensitivity; heterogeneity may explain no overall baseline-to-follow-up change in GR sensitivity.
- Evident from the text: treatment was naturalistic “treatment as usual” without controlling for treatment type or dose; the ex vivo peripheral blood assay is an indirect proxy for GR/HPA axis function rather than a direct HPA axis measurement.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
0 Valid · 1 Not valid · 39 Not checked · 49 Own results and interpretations
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Higher baseline logEC IL-10 (indicating a lower GR sensitivity) and a stronger reduction of logEC IL-10 (indicating a stronger increase in GR sensitivity) were associated with a stronger decrease in the MADRS score.”
- Also stated in: § Correlations in patients with a current MDE · plain
“positively with logEC IL-10 course”
§ Ex vivo glucocorticoid receptor-mediated IL-10 response predicts the course of depression severity > Abstract
plainstates an associationn = 87 ·- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Correlations in patients with a current MDE · plain
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Higher baseline scores of the Montgomery–Åsberg Depression Rating Scale (MADRS) were associated with a stronger decrease of logIC IL-6 (indicating an increase of GR sensitivity).”
- Also stated in: § Correlations in patients with a current MDE · plain
“baseline MADRS scores significantly negatively correlated with the logIC IL-6 course (Table 3).”
§ Ex vivo glucocorticoid receptor-mediated IL-10 response predicts the course of depression severity > Abstract
plainstates an associationn = 87 ·- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Correlations in patients with a current MDE · plain
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Neither the logIC IL-6, logEC IL-10, and logIC TNF-α values at baseline, follow-up, nor their overall courses significantly correlated with depression severity scores or course measured by the BDI-II or the HAMD (data not shown).”
§ Ex vivo glucocorticoid receptor-mediated IL-10 response predicts the course of depression severity > Results > Correlations in patients with a current MDE
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Patients with remitted MDD showed higher logIC TNF-α values (indicating lower GR sensitivity) in comparison to patients with a current MDD at baseline and follow-up.”
- Also stated in: § Group differences and time course · plain
“we found significantly higher logIC TNF-α in patients with remitted MDD than in patients with a current MDE at both time points (Table 2).”
§ Ex vivo glucocorticoid receptor-mediated IL-10 response predicts the course of depression severity > Abstract
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Group differences and time course · plain
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The patients with a current MDE did not significantly differ from the healthy control subjects by sex, relationship status, age, or education level (years), but were significantly more likely to be divorced and scored significantly higher on the BDI-II, the HAMD, and the MADRS.”
§ Ex vivo glucocorticoid receptor-mediated IL-10 response predicts the course of depression severity > Results > Cohort characteristics
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
29 more claims
Create a free account to see all 89 claims and to verify the 66 references still open.
- It may state two separate claims as one. 12
- Probably not a substantial claim. 51
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Ex vivo glucocorticoid receptor-mediated IL-10 response predicts the course of depression severity > Results > Cohort characteristics
“| Divorced (%) | 87 | 20.7 | | | 48 | 6.3 | | | 30 | 36.7 | | | 4.9, 1 | 0.027a | 3.1, 1 | 0.081a |”
§ Ex vivo glucocorticoid receptor-mediated IL-10 response predicts the course of depression severity > Results > Cohort characteristics
“| Single (%) | 87 | 35.6 | | | 49 | 26.5 | | | 31 | 32.3 | | | 1.2, 1 | 0.276a | 0.1, 1 | 0.735a | | Married (%) | 87 | 42.5 | | | 49 | 38.8 | | | 31 | 58.1 | | | 0.2, 1 | 0.669a | 2.2, 1 | 0.137a |”
Citations
Cites
A new depression scale designed to be sensitive to change
Montgomery, S. A., & Åsberg, M. (1979) · British Journal of Psychiatry · doi:10.1192/bjp.134.4.382 · Cited by 13,962
Vos, T., Abajobir, A. A., Abate, K. H., Abbafati, C., Abbas, K. M., Abd-Allah, F., Abdulkader, R. S., Abdulle, A. M., Abebo, T. A., Abera, S. F., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)32154-2 · Cited by 13,220
The role of inflammation in depression: from evolutionary imperative to modern treatment target
Miller, A. H., & Raison, C. L. (2016) · Nature Reviews Immunology · doi:10.1038/nri.2015.5 · Cited by 3,942 · cited 2×
“The interaction of the immune system with neurocircuits seems to modulate the risk for depression (Haapakoski et al. 2016; Miller and Raison 2016).”
BackgroundInflammation and Its Discontents: The Role of Cytokines in the Pathophysiology of Major Depression
Miller, A. H., Maletic, V., & Raison, C. L. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.11.029 · Cited by 3,848
The regulation of IL-10 production by immune cells
Saraiva, M., & O'Garra, A. (2010) · Nature Reviews Immunology · doi:10.1038/nri2711 · Cited by 3,164
The Corticosteroid Receptor Hypothesis of Depression
Holsboer, F. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00159-7 · Cited by 2,181
Belmaker, R. H., & Agam, G. (2008) · New England Journal of Medicine · doi:10.1056/nejmra073096 · Cited by 2,166
Raison, C. L., Rutherford, R. E., Woolwine, B. J., Shuo, C., Schettler, P., Drake, D. F., Haroon, E., & Miller, A. H. (2013) · JAMA Psychiatry · doi:10.1001/2013.jamapsychiatry.4 · Cited by 1,617
A mechanism converting psychosocial stress into mononuclear cell activation
Bierhaus, A., Wolf, J., Andrassy, M., Rohleder, N., Humpert, P. M., Petrov, D., Ferstl, R., von Eynatten, M., Wendt, T., Rudofsky, G., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0438019100 · Cited by 927
Inflammation: Depression Fans the Flames and Feasts on the Heat
Kiecolt-Glaser, J. K., Derry, H. M., & Fagundes, C. P. (2015) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2015.15020152 · Cited by 844 · cited 14×
“Furthermore, inflammatory processes are associated with the symptoms of MDD (Kiecolt-Glaser et al.”
BackgroundInfluentialPace, T. W. W., Mletzko, T. C., Alagbe, O., Musselman, D. L., Nemeroff, C. B., Miller, A. H., & Heim, C. M. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.9.1630 · Cited by 810
Silverman, M. N., & Sternberg, E. M. (2012) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2012.06633.x · Cited by 731
Integrating neuroimmune systems in the neurobiology of depression
Wohleb, E. S., Franklin, T., Iwata, M., & Duman, R. S. (2016) · Nature Reviews Neuroscience · doi:10.1038/nrn.2016.69 · Cited by 668 · cited 14×
“Furthermore, inflammatory processes are associated with the symptoms of MDD (Kiecolt-Glaser et al.”
BackgroundInfluentialThe combined dexamethasone/CRH test: A refined laboratory test for psychiatric disorders
Heuser, I., Yassouridis, A., & Holsboer, F. (1994) · Journal of Psychiatric Research · doi:10.1016/0022-3956(94)90017-5 · Cited by 662
The glucocorticoid receptor: Pivot of depression and of antidepressant treatment?
Anacker, C., Zunszain, P. A., Carvalho, L. A., & Pariante, C. M. (2011) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2010.03.007 · Cited by 592
Köhler, C. A., Freitas, T. H., Stubbs, B., Maes, M., Solmi, M., Veronese, N., de Andrade, N. Q., Morris, G., Fernandes, B. S., Brunoni, A. R., et al. (2017) · Molecular Neurobiology · doi:10.1007/s12035-017-0632-1 · Cited by 449
Liu, J. J., Wei, Y. B., Strawbridge, R., Bao, Y., Chang, S., Shi, L., Que, J., Gadad, B. S., Trivedi, M. H., Kelsoe, J. R., et al. (2020) · Molecular Psychiatry · doi:10.1038/s41380-019-0474-5 · Cited by 429
Zobel, A. W., Nickel, T., Sonntag, A., Uhr, M., Holsboer, F., & Ising, M. (2001) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(01)00013-9 · Cited by 354
Ising, M., Horstmann, S., Kloiber, S., Lucae, S., Binder, E. B., Kern, N., Künzel, H. E., Pfennig, A., Uhr, M., & Holsboer, F. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.07.039 · Cited by 341 · cited 1×
“2007; Jokinen and Nordström 2009; Lenz et al.”
The DST as a predictor of outcome in depression: a meta-analysis
Ribeiro, S. C. M., Tandon, R., Grunhaus, L., & Greden, J. F. (1993) · American Journal of Psychiatry · doi:10.1176/ajp.150.11.1618 · Cited by 329
The Dexamethasone Suppression Test and Suicide Prediction
Coryell, W., & Schlesser, M. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.5.748 · Cited by 304
Repeated dexamethasone suppression test during depressive illness
Holsboer, F., Liebl, R., & Hofschuster, E. (1982) · Journal of Affective Disorders · doi:10.1016/0165-0327(82)90039-8 · Cited by 301
Sex differences and the neurobiology of affective disorders
Rubinow, D. R., & Schmidt, P. J. (2019) · Neuropsychopharmacology · doi:10.1038/s41386-018-0148-z · Cited by 280
Resistance to Suppression by Dexamethasone of Plasma 11-O.H.C.S. Levels in Severe Depressive Illness
Carroll, B. J., Martin, F. I. R., & Davies, B. (1968) · BMJ · doi:10.1136/bmj.3.5613.285 · Cited by 279
The evolutionary significance of depression in Pathogen Host Defense (PATHOS-D)
Raison, C. L., & Miller, A. H. (2013) · Molecular Psychiatry · doi:10.1038/mp.2012.2 · Cited by 253 · cited 1×
“It has been assumed that “sickness behavior” promotes host survival during infections (Raison and Miller 2013).”
BackgroundClinical depression and regulation of the inflammatory response during acute stress
Miller, G. E., Rohleder, N., Stetler, C., & Kirschbaum, C. (2005) · Psychosomatic Medicine · doi:10.1097/01.psy.0000174172.82428.ce · Cited by 253
Is the HPA Axis as Target for Depression Outdated, or Is There a New Hope?
Menke, A. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00101 · Cited by 240
Rybakowski, J. K., & Twardowska, K. (1999) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(99)00014-x · Cited by 213
Kunugi, H., Ida, I., Owashi, T., Kimura, M., Inoue, Y., Nakagawa, S., Yabana, T., Urushibara, T., Kanai, R., Aihara, M., et al. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300868 · Cited by 200
Hennings, J. M., Owashi, T., Binder, E. B., Horstmann, S., Menke, A., Kloiber, S., Dose, T., Wollweber, B., Spieler, D., Messer, T., et al. (2009) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2008.05.002 · Cited by 195
Glucocorticoids Play a Fundamental Role in Protecting the Brain during Innate Immune Response
Nadeau, S., & Rivest, S. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-13-05536.2003 · Cited by 190
Haapakoski, R., Ebmeier, K. P., Alenius, H., & Kivimäki, M. (2016) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2015.11.012 · Cited by 157
Appelhof, B. C., Huyser, J., Verweij, M., Brouwer, J. P., van Dyck, R., Fliers, E., Hoogendijk, W. J. G., Tijssen, J. G. P., Wiersinga, W. M., & Schene, A. H. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.09.008 · Cited by 154
Reppermund, S., Zihl, J., Lucae, S., Horstmann, S., Kloiber, S., Holsboer, F., & Ising, M. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.09.027 · Cited by 147
Husain, M. I., Chaudhry, I. B., Husain, N., Khoso, A. B., Rahman, R. R., Hamirani, M. M., Hodsoll, J., Qurashi, I., Deakin, J. F., & Young, A. H. (2017) · Journal of Psychopharmacology · doi:10.1177/0269881117724352 · Cited by 144
HPA axis hyperactivity and attempted suicide in young adult mood disorder inpatients
Jokinen, J., & Nordström, P. (2009) · Journal of Affective Disorders · doi:10.1016/j.jad.2008.10.015 · Cited by 143
Hypothalamic–pituitary–adrenal axis function in patients with chronic depression
WATSON, S., GALLAGHER, P., DEL-ESTAL, D., HEARN, A., FERRIER, I. N., & YOUNG, A. H. (2002) · Psychological Medicine · doi:10.1017/s0033291702005998 · Cited by 130
LDL cholesterol relates to depression, its severity, and the prospective course
Wagner, C. J., Musenbichler, C., Böhm, L., Färber, K., Fischer, A.-I., von Nippold, F., Winkelmann, M., Richter-Schmidinger, T., Mühle, C., Kornhuber, J., et al. (2019) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2019.01.010 · Cited by 106
Self-citationCeramides and depression: A systematic review
Dinoff, A., Herrmann, N., & Lanctôt, K. L. (2017) · Journal of Affective Disorders · doi:10.1016/j.jad.2017.02.008 · Cited by 105
Binder, E. B., Künzel, H. E., Nickel, T., Kern, N., Pfennig, A., Majer, M., Uhr, M., Ising, M., & Holsboer, F. (2009) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2008.08.018 · Cited by 99
A Review of Hypothalamic-Pituitary-Adrenal Axis Function in Chronic Fatigue Syndrome
Tomas, C., Newton, J., & Watson, S. (2013) · ISRN Neuroscience · doi:10.1155/2013/784520 · Cited by 98
A central role for the acid sphingomyelinase/ceramide system in neurogenesis and major depression
Gulbins, E., Walter, S., Becker, K. A., Halmer, R., Liu, Y., Reichel, M., Edwards, M. J., Müller, C. P., Fassbender, K., & Kornhuber, J. (2015) · Journal of Neurochemistry · doi:10.1111/jnc.13145 · Cited by 93
Self-citationSchüle, C., Baghai, T. C., Eser, D., Häfner, S., Born, C., Herrmann, S., & Rupprecht, R. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004324 · Cited by 83
The DEX/CRH test for major depression: A potentially useful diagnostic test
Mokhtari, M., Arfken, C., & Boutros, N. (2013) · Psychiatry Research · doi:10.1016/j.psychres.2012.09.032 · Cited by 79
DST non-suppression predicts suicide after attempted suicide
Jokinen, J., Carlborg, A., Mårtensson, B., Forslund, K., Nordström, A.-L., & Nordström, P. (2007) · Psychiatry Research · doi:10.1016/j.psychres.2006.12.001 · Cited by 77
The role of ceramide in major depressive disorder
Kornhuber, J., Reichel, M., Tripal, P., Groemer, T. W., Henkel, A. W., Mühle, C., & Gulbins, E. (2009) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-009-0061-x · Cited by 68
Self-citationGlucocorticoid Sensitivity in Young Healthy Individuals:in Vitro and in Vivo Studies
Chriguer, R. S., Elias, L. L. K., da Silva, I. M., Vieira, J. G. H., Moreira, A. C., & de Castro, M. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0067 · Cited by 68
Bekhbat, M., Chu, K., Le, N.-A., Woolwine, B. J., Haroon, E., Miller, A. H., & Felger, J. C. (2018) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2018.09.004 · Cited by 64
The androgen model of suicide completion
Lenz, B., Röther, M., Bouna-Pyrrou, P., Mühle, C., Tektas, O. Y., & Kornhuber, J. (2018) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2018.06.003 · Cited by 62
Self-citationHardeveld, F., Spijker, J., Vreeburg, S. A., Graaf, R. D., Hendriks, S. M., Licht, C. M. M., Nolen, W. A., Penninx, B. W. J. H., & Beekman, A. T. F. (2014) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2014.07.027 · Cited by 58
Aubry, J.-M., Gervasoni, N., Osiek, C., Perret, G., Rossier, M. F., Bertschy, G., & Bondolfi, G. (2007) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2006.07.007 · Cited by 58
In vitro modulation of the glucocorticoid receptor by antidepressants
Carvalho, L. A., & Pariante, C. M. (2008) · Stress · doi:10.1080/10253890701850759 · Cited by 56
Childhood trauma dependent anxious depression sensitizes HPA axis function
Menke, A., Lehrieder, D., Fietz, J., Leistner, C., Wurst, C., Stonawski, S., Reitz, J., Lechner, K., Busch, Y., Weber, H., et al. (2018) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2018.07.025 · Cited by 55 · cited 1×
“2016; Miller and Raison 2016).”
Cytokine release and its modulation by dexamethasone in whole blood following exercise
Smits, H. H., Grünberg, K., Derijk, R. H., Sterk, P. J., & Hiemstra, P. S. (2001) · Clinical and Experimental Immunology · doi:10.1046/j.1365-2249.1998.00482.x · Cited by 54
van den Bosch, M. W. M., Palsson-Mcdermott, E., Johnson, D. S., & O'Neill, L. A. J. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.573089 · Cited by 54
Bellingrath, S., Rohleder, N., & Kudielka, B. M. (2013) · Biological Psychology · doi:10.1016/j.biopsycho.2012.12.003 · Cited by 45
Mühle, C., Wagner, C., Färber, K., Richter‐Schmidinger, T., Gulbins, E., Lenz, B., & Kornhuber, J. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8060846 · Cited by 39
Self-citationVisser, J., Graffelman, W., Blauw, B., Haspels, I., Lentjes, E., de Kloet, E. R., & Nagelkerken, L. (2001) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(01)00400-3 · Cited by 37
von Zimmermann, C., Winkelmann, M., Richter‐Schmidinger, T., Mühle, C., Kornhuber, J., & Lenz, B. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.00494 · Cited by 36
Self-citationSphingomyelin Synthases in Neuropsychiatric Health and Disease
Mühle, C., Canalejas, R. D. B., & Kornhuber, J. (2019) · Neurosignals · doi:10.33594/000000200 · Cited by 32
Self-citationCai, D.-B., Zheng, W., Zhang, Q.-E., Ng, C. H., Ungvari, G. S., Huang, X., & Xiang, Y. (2020) · Psychiatric Quarterly · doi:10.1007/s11126-019-09707-3 · Cited by 29
Altered Glucocorticoid Regulation of the Immune Response in the Chronic Fatigue Syndrome
Visser, J. T. J., de Kloet, E. R., & Nagelkerken, L. M. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb05453.x · Cited by 28
Alternative splicing of SMPD1 coding for acid sphingomyelinase in major depression
Rhein, C., Reichel, M., Kramer, M., Rotter, A., Lenz, B., Mühle, C., Gulbins, E., & Kornhuber, J. (2016) · Journal of Affective Disorders · doi:10.1016/j.jad.2016.09.019 · Cited by 28
Self-citationBlood-based biomarkers predicting response to antidepressants
Busch, Y., & Menke, A. (2019) · Journal of Neural Transmission · doi:10.1007/s00702-018-1844-x · Cited by 27
Behnken, A., Bellingrath, S., Symanczik, J.-P., Rieck, M. J., Zavorotnyy, M., Domschke, K., Arolt, V., & Zwanzger, P. (2013) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2012.07.005 · Cited by 24
Monocytes from Depressed Patients Display an Altered Pattern of Response to Endotoxin Challenge
Lisi, L., Camardese, G., Treglia, M., Tringali, G., Carrozza, C., Janiri, L., Russo, C. D., & Navarra, P. (2013) · PLoS ONE · doi:10.1371/journal.pone.0052585 · Cited by 24
Pintor, L., Torres, X., Navarro, V., Martinez de Osaba, M. J., Matrai, S., & Gastó, C. (2007) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2007.03.002 · Cited by 16
ter Wolbeek, M., van Doornen, L. J. P., Schedlowski, M., Janssen, O. E., Kavelaars, A., & Heijnen, C. J. (2008) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2007.12.005 · Cited by 15
Reduction of Glucocorticoid Receptor Function in Chronic Fatigue Syndrome
Lynn, M., Maclachlan, L., Finkelmeyer, A., Clark, J., Locke, J., Todryk, S., Ng, W.-F., Newton, J. L., & Watson, S. (2018) · Mediators of Inflammation · doi:10.1155/2018/3972104 · Cited by 13
Multiple depressive episodes and plasma postdexamethasone cortisol levels
Meador‐Woodruff, J. H., Gurguis, G. N. M., Grunhaus, L. J., Haskett, R. F., & Greden, J. F. (1987) · Biological Psychiatry · doi:10.1016/0006-3223(87)90186-7 · Cited by 11
Lymphocyte glucocorticoid receptor resistance and depressive symptoms severity: A preliminary report
Tanke, M. A. C., Bosker, F. J., Gladkevich, A. V., Medema, H. M., den Boer, J. A., & Korf, J. (2008) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2008.04.006 · Cited by 7
Ex vivo stimulation of whole blood as a means to determine glucocorticoid sensitivity
Webster-Marketon, J., Burnsides, Corry, Alexander, Balint, Cosmar, & Philips (2012) · Journal of Inflammation Research · doi:10.2147/jir.s33569 · Cited by 4
Cited by
mRNA Expression of SMPD1 Encoding Acid Sphingomyelinase Decreases upon Antidepressant Treatment
Rhein, C., Zoicas, I., Marx, L. M., Zeitler, S., Hepp, T., von Zimmermann, C., Mühle, C., Richter‐Schmidinger, T., Lenz, B., Erim, Y., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22115700 · Cited by 24
Self-citationMacrophage Migration Inhibitory Factor in Major Depressive Disorder: A Multilevel Pilot Study
Swoboda, C., Deloch, L., von Zimmermann, C., Richter‐Schmidinger, T., Lenz, B., Kornhuber, J., & Mühle, C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232415460 · Cited by 15
Self-citationBrazdis, R.-M., von Zimmermann, C., Lenz, B., Kornhuber, J., & Mühle, C. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25063219 · Cited by 13
Self-citationNoortgate, M. V. D., Eede, F. V. D., Coppens, V., Giltay, E. J., Picker, L. D., & Morrens, M. (2025) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2025.100965 · Cited by 12
Kind, L., Luttenberger, K., Leßmann, V., Dorscht, L., Mühle, C., Müller, C. P., Siegmann, E.-M., Schneider, S., & Kornhuber, J. (2023) · Trials · doi:10.1186/s13063-023-07629-x · Cited by 12
Self-citation
Metadata
- Authors
- von Zimmermann, C., Böhm, L., Richter-Schmidinger, T., Kornhuber, J., Lenz, B., & Mühle, C.
- Affiliations
- Friedrich-Alexander-Universität Erlangen-Nürnberg (DE)
- Corresponding author
- von Zimmermann, Claudia
- ORCID
- Venue
- Journal of Neural Transmission
- Published
- 2021-01
- Volume
- 128
- Issue
- 1
- Pages
- 95-104
- ISSN
- 0300-9564 (ISSN-L)
- 1435-1463
- PMC
- PMC7815576
- OpenAlex
- W3120135266
- Semantic Scholar
- 129792cfff0438737c91f5ad771b3d7c2cc02a8d
- Cited by
- 13
- References
- 72
- Citations by year
- 2026: 1 · 2025: 4 · 2024: 4 · 2023: 2 · 2022: 1 · 2021: 1
- FWCI
- 1.07
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor, 14 d)
- Locations
- Journal of Neural Transmission (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Informationszentrum Lebenswissenschaften (ZB MED) (submittedVersion, cc-by)
- OPUS FAU (Kooperativer Bibliotheksverbund Berlin-Brandenburg (KOBV), on behalf of the Universitätsbibliothek Erlangen-Nürnberg) (submittedVersion, cc-by)
- Funders
- Bundesministerium für Bildung und Forschung (01EE1401C)
- Deutsche Forschungsgemeinschaft (KO 947/13-1, 270949263/GRK2162)
- Projekt DEAL
- Topics
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Keywords
- glucocorticoid receptor sensitivity, major depressive disorder, depression severity prediction, hypothalamic-pituitary-adrenal axis, IL-10, interleukin-6, TNF-α, lipopolysaccharide stimulation, dexamethasone, cytokine production, peripheral blood mononuclear cells, remitted depression, treatment response
- MeSH terms
- Depression, Major Depressive Disorder, Dexamethasone, Humans, Hydrocortisone, Hypothalamo-Hypophyseal System, Pituitary-Adrenal System, Receptors, Glucocorticoid, Interleukin-10
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-11-21, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-11-21 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.